11/12/2026
Now Enrolling: New Clinical Trial for Locally Advanced or Metastatic Hormone Positive Breast Cancer!
You may be eligible to participate if:
• Male or female at least 18 years of age
• You have been diagnosed with ER+/HER2- locally advanced or
metastatic breast cancer
• You have not had any treatment in the advanced or metastatic setting
Please visit the link below for more information!
A Phase 3 Study Investigating BGB-43395 Plus Letrozole Versus CDK4/6 Inhibitors Plus Letrozole in Patients With Advanced or Metastatic HR+/H...